“Impact on the quality of life of the treatment of adductor spasmodic dysphonia with botulinum toxin A”, Rev. Investig. Innov. Cienc. Salud, vol. 3, no. 2, pp. 24–34, Dec. 2021, doi: 10.46634/riics.66.